当前位置： SCI文献检索 > BMC Medical Genetics期刊下所有文献 > Mapping the deletion endpoints in individuals with 22q11.2 deletion syndrome by droplet digital PCR.

Mapping the deletion endpoints in individuals with 22q11.2 deletion syndrome by droplet digital PCR.

Abstract：

BACKGROUND:Chromosome 22q11.2 deletion syndrome (22q11DS) is the most common human microdeletion syndrome and is associated with many cognitive, neurological and psychiatric disorders. The majority of individuals have a 3 Mb deletion while others have a nested 1.5 Mb deletion, but rare atypical deletions have also been described. To date, a study using droplet digital PCR (ddPCR) has not been conducted to systematically map the chromosomal breakpoints in individuals with 22q11DS, which would provide important genotypic insight into the various phenotypes observed in this syndrome. METHODS:This study uses ddPCR to assess copy number (CN) changes within the chromosome 22q11 deletion region and allows the mapping of the deletion endpoints. We used eight TaqMan assays interspersed throughout the deleted region of 22q11.2 to characterize the deleted region of chromosome 22 in 80 individuals known to have 22q11DS by FISH. Ten EvaGreen assays were used for finer mapping of the six identified individuals with 22q11DS atypical deletions and covering different regions of chromosome 22. RESULTS:ddPCR provided non-ambiguous CN measurements across the region, confirmed the presence of the deletion in the individuals screened, and led to the identification of five differently sized and located deletions. The majority of the participants (n = 74) had the large 3 Mb deletions, whereas three had the smaller 1.5 Mb deletions, and the remaining three had an interstitial deletion of different size. CONCLUSIONS:The lower cost, rapid execution and high reliability and specificity provided by ddPCR for CN measurements in the 22q11 region constitutes a significant improvement over the variable CN values generated by other technologies. The ability of the ddPCR approach, to provide a high resolution mapping of deletion endpoints may result in the identification of genes that are haplo-insufficient and play a role in the pathogenesis of 22q11DS. Finally, this methodology can be applied to the characterization of other microdeletions throughout the genome.

journal_name

BMC Med Genet

journal_title

BMC medical genetics

authors

Hwang VJ,Maar D,Regan J,Angkustsiri K,Simon TJ,Tassone F

doi

10.1186/s12881-014-0106-5

subject

Has Abstract

pub_date

2014-10-14 00:00:00

pages

106

issn

1471-2350

pii

s12881-014-0106-5

journal_volume

pub_type

杂志文章

在线工具

Mapping the deletion endpoints in individuals with 22q11.2 deletion syndrome by droplet digital PCR.